Verification evidence is still being completed.
PDF / print export
Nordic Biomarker
Umea, Sweden
- Verified lead
- Rikard Roden
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Coagulation Diagnostics, Hemostasis Reagents, IVD Products, Assay Development, and Diagnostics Operations
- Review cycle
- May 2026
- Full address
- Vildmannavagen 1, 903 47 Umea, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Nordic Biomarker contact page confirming the Umea address.
- Editorial note
- Nordic Biomarker is published because official company materials confirm current leadership, Umea headquarters address, and a real diagnostics and reagent platform.
Coagulation Diagnostics, Hemostasis Reagents, IVD Products, Assay Development, and Diagnostics Operations
Official leadership disclosure, Official Umea address disclosure, ISO 13485 disclosure
Nordic Biomarker is published because official company materials confirm current leadership, Umea headquarters address, and a real diagnostics and reagent platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Umea, Sweden
Nordic Biomarker
Coagulation Diagnostics, Hemostasis Reagents, IVD Products, Assay Development, and Diagnostics Operations · Diagnostics platform
Nordic Biomarker runs ivd reagent development, coagulation assay portfolio, and diagnostics quality-system operations in Umea, Sweden.
- Lead
- Rikard Roden (verified ↗)
- Address
- Vildmannavagen 1, 903 47 Umea, Sweden (source ↗)
- Compliance
- ISO 13485 disclosure
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- IVD Reagent Development · Coagulation Assay Portfolio · Diagnostics Quality-System Operations
- Founded
- 1986
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Rikard Roden
CEO
Full addressVildmannavagen 1, 903 47 Umea, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Nordic Biomarker contact page listing the Umea headquarters address.
Open sourceDiagnostics platform
Umea, Sweden. Coagulation Diagnostics, Hemostasis Reagents, IVD Products, Assay Development, and Diagnostics Operations. Review completed on 21 Mar 2026.
Swedish diagnostics and IVD oversight
Official leadership disclosure, Official Umea address disclosure, ISO 13485 disclosure
Coagulation Diagnostics, Hemostasis Reagents, IVD Products, Assay Development, and Diagnostics Operations
Nordic Biomarker is published because official company materials confirm current leadership, Umea headquarters address, and a real diagnostics and reagent platform.
Editorial note
Nordic Biomarker is published because official company materials confirm current leadership, Umea headquarters address, and a real diagnostics and reagent platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
IVD Reagent Development
Coagulation Assay Portfolio
Diagnostics Quality-System Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Coagulation assay workflow
Diagnostics quality systems
Reagent operations infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Nordic Biomarker located?
- Nordic Biomarker operates from Vildmannavagen 1, 903 47 Umea, Sweden, Umea, Sweden.
- Who runs Nordic Biomarker?
- Nordic Biomarker is led by Rikard Roden, CEO. Verified 21 Mar 2026.
- What certifications does Nordic Biomarker hold?
- Nordic Biomarker is documented under ISO 13485 disclosure.
- What does Nordic Biomarker do?
- Nordic Biomarker runs ivd reagent development, coagulation assay portfolio, and diagnostics quality-system operations in Umea, Sweden. Core capabilities: IVD Reagent Development, Coagulation Assay Portfolio, Diagnostics Quality-System Operations.
Editorial context
Related technical briefs
Briefs that name Umea as a covered market or city.